Bolus vincristine and epirubicin with cyclophosphamide and dexamethasone (VECD) as induction and salvage treatment in multiple myeloma.
第一作者:
A,Fosså
第一单位:
Department of Internal Medicine (Cancer Research), West German Cancer Center, University of Essen.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);地塞米松(Dexamethasone);无病生存(Disease-Free Survival);多柔比星(Doxorubicin);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);复发(Recurrence);缓解诱导(Remission Induction);挽救疗法(Salvage Therapy);存活率(Survival Rate);长春新碱(Vincristine)
DOI
10.1038/sj.leu.2400945
PMID
9529138
发布时间
2019-09-14
- 浏览26

Leukemia
422-6页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文